Open access · CC-BY
via OpenAlex
Cellular Senescence and Brain Aging: The Therapeutic Promise of Senolytics in Neurodegenerative Diseases – A Scoping Review
Made Putri Pradnya Wati, Dewa Ayu Agus Sri Laksemi, I Made Winarsa Ruma
Neurologico Spinale Medico Chirurgico · 2026
Cellular senescence
Chronic inflammation
Senolytics
Human
Systematic review
Preclinical / animal
Review
Abstract
A BSTRACT Cellular senescence(definition) is increasingly recognized as a key driver of brain aging and neurodegenerative diseases. Senolytic drugs that selectively eliminate senescent cells have emerged as a promising therapeutic strategy. This scoping review maps the current evidence on senolytic interventions targeting cellular senescence in brain aging and neurodegenerative diseases. We conducted a systematic search across Google Scholar, PubMed, and ClinicalTrials.gov (2015–2025). Studies were screened and data extracted using standardized forms. Results were synthesized thematically following Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. Of 48 records screened, 46 studies were included (3 clinical trials, 24 preclinical studies, 19 reviews). Two clinical trials (SToMP-AD and STAMINA) demonstrated safety and target engagement of dasatinib + quercetin (D + Q) in Alzheimer’s disease. Preclinical evidence strongly supports senolytic efficacy in improving cognition and reducing neuroinflammation. Senolytic therapy shows promise for neurodegenerative diseases, but larger clinical trials are needed. Critical gaps include optimal dosing, biomarker development, and long-term safety data.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4103/nsmc.nsmc_11_26
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Wati, M.P.P., Laksemi, D.A.A.S., & Ruma, I.M.W. (2026). Cellular Senescence and Brain Aging: The Therapeutic Promise of Senolytics in Neurodegenerative Diseases – A Scoping Review. <em>Neurologico Spinale Medico Chirurgico</em>. https://doi.org/10.4103/nsmc.nsmc_11_26
Vancouver
Wati MPP, Laksemi DAAS, Ruma IMW. Cellular Senescence and Brain Aging: The Therapeutic Promise of Senolytics in Neurodegenerative Diseases – A Scoping Review. Neurologico Spinale Medico Chirurgico. 2026. doi:10.4103/nsmc.nsmc_11_26.
BibTeX
@article{made2026Cellul,
title = {Cellular Senescence and Brain Aging: The Therapeutic Promise of Senolytics in Neurodegenerative Diseases – A Scoping Review},
author = {Made Putri Pradnya Wati and Dewa Ayu Agus Sri Laksemi and I Made Winarsa Ruma},
journal = {Neurologico Spinale Medico Chirurgico},
year = {2026},
doi = {10.4103/nsmc.nsmc_11_26},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
British Journal of Clinical Pharmacology 2026
Open access · OA
Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti‐ageing therapies in human clinical trials
British journal of clinical pharmacology 2026
Citation only
Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials.
Preprints.org 2026
Preprint · CC-BY
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
2026
Preprint
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
2026
Open access · OA
Senolytic therapy in Alzheimer’s disease: clinical evidence and biomarkers
International Journal of Molecular Sciences 2026
Open access · CC-BY